Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
NORTHBROOK, Ill., May 27, 2020 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the U.S. Food and Drug Administration...
NORTHBROOK, Ill., April 30, 2020 /PRNewswire/ -- With more and more Americans facing economic hardships as a result of the COVID-19 pandemic, Astellas has implemented changes to its patient...
- New Funding will Address Disparities in Mental Health Diagnosis and Treatment for 400,000 People in Need - NORTHBROOK, Ill. and INDIANAPOLIS, Feb. 10, 2020 /PRNewswire/ -- The Astellas Global...
NORTHBROOK, Ill., Jan. 21, 2020 /PRNewswire/ -- For the sixth consecutive year, Astellas has achieved a perfect score on the Human Rights Campaign Foundation's (HRC) annual Corporate Equality...
NORTHBROOK, Ill., Jan. 8, 2020 /PRNewswire/ -- Astellas Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for...
Follow U.S. news
